572 Generics, 945 Brand Names

1. Establishment and Growth: Founded in 1958, Square Pharmaceuticals Ltd. has grown steadily to become Bangladesh's largest pharmaceutical company. It transitioned into a public limited company in 1991 and was listed on stock exchanges in 1995.
2. Market Leadership: Since 1985, Square Pharmaceuticals has consistently held the top position among all national and multinational pharmaceutical companies in Bangladesh. It boasts a significant market share, with a turnover of BDT 50.87 billion (US$ 609.18 million) and a growth rate of about 10.85% as of July 2018–June 2019.
3. Global Expansion: Square Pharmaceuticals PLC has expanded its services beyond Bangladesh's borders, venturing into the global market. It initiated exports of medicines from Bangladesh in 1987, specializing in antibiotics and other pharmaceutical products. Its export market now spans 42 countries, demonstrating the company's credibility and commitment to global outreach.
4. Diversification and Innovation: Square Pharmaceuticals PLC has diversified its product range and embraced innovation to stay competitive in the pharmaceutical industry. Its commitment to research and development, coupled with a focus on quality, has enabled the company to adapt to evolving market demands and maintain its leadership position.
5. Corporate Governance and Sustainability: As a publicly listed company, Square Pharmaceuticals PLC adheres to stringent corporate governance standards, ensuring transparency and accountability in its operations. The company also prioritizes sustainability initiatives, striving to minimize its environmental footprint and contribute positively to society.

In conclusion, Square Pharmaceuticals PLC's journey from its humble beginnings in 1958 to its current status as Bangladesh's leading pharmaceutical company reflects a remarkable story of perseverance, innovation, and strategic vision. With a strong foothold in the domestic market and a growing presence in the global arena, Square Pharmaceuticals PLC is poised for continued success and further expansion in the years to come.